Logo

Qiagen s Acquisition of Eppendorf Tops Most-Read GenomeWeb Daily News Stories Last Week

Jan 09, 2006

NEW YORK, Jan. 9 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Jan. 6.

 

1. Qiagen Acquires Eppendorf's Reagent Business; Firms to Align Techs (from Jan. 5)

2. As 454 Enabled Mammoth Project, Next-Generation Sequencers Will Drive Paleogenomics (from Jan. 3)

3. Predictive Diagnostics Closes Doors as Nasdaq Delists LSBC (from Jan. 3)

4. Third Wave CEO Gets New Salary; FDA Names Acting Tox Director; Exiqon Announces Head of US Operations; and Others (from Jan. 4)

5. Without Roche, Epigenomics Completes Validation Study for Prostate Cancer Dx (from Jan. 4)

Breaking News
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.